title: Immunological effects of insulin-like growth factor-I--enhancement of immunoglobulin synthesis.
abstract: In addition to its activity as a metabolic hormone and a regulator of somatic growth, insulin-like growth factor-I (IGF-I) has cytokine-like activities on lymphoid cells. A 14-day infusion of recombinant human (rh)IGF-I increased lymphocyte numbers in all the peripheral lymphoid organs examined. This increase was apparent for up to 3 weeks following cessation of hormone treatment. A second administration of rhIGF-I, given when the lymphocyte numbers in the rhIGF-I-treated mice had returned to control values, resulted in similar increases in the peripheral T and B cell populations. This increase in lymphocyte numbers had functional significance, since rhIGF-I-treated mice produced elevated antibody titres following primary or secondary antigen challenge compared with controls. In addition, when rhIGF-I-treated mice were immunized with a suboptimal dose of antigen they produced antibody titres which were equivalent to those generated by immunization with optimal doses of antigen. When examined in vitro, addition of rhIGF-I alone to cultures of splenocytes from antigen-primed mice stimulated immunoglobulin synthesis. These studies suggest that IGF-I produced locally by thymic and bone marrow stromal cells may be a natural component of B and T cell lymphopoiesis.
authors.affiliation: Department of Immunology, Genentech, Inc., South San Francisco, CA 94080.
authors.forename: K
authors.initials: K
authors.lastname: Robbins
authors.forename: S
authors.initials: S
authors.lastname: McCabe
authors.forename: T
authors.initials: T
authors.lastname: Scheiner
authors.forename: J
authors.initials: J
authors.lastname: Strasser
authors.forename: R
authors.initials: R
authors.lastname: Clark
authors.forename: P
authors.initials: P
authors.lastname: Jardieu
mesh_terms: D000818:Animals; D000941:Antigens / Q000276:immunology; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D001835:Body Weight / Q000187:drug effects; D007136:Immunoglobulins / Q000096:biosynthesis*; D016130:Immunophenotyping; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009929:Organ Size / Q000187:drug effects; D011994:Recombinant Proteins / Q000494:pharmacology
chemical_list: D000941:Antigens; D007136:Immunoglobulins; D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I